Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Biomarker Analysis in Patients (pts) with Steroid-Refractory Acute Graft-Vs-Host Disease (aGVHD) Treated with Ruxolitinib (RUX) or Best Available Therapy (BAT) in the Randomized, Phase 3 REACH2 Study

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-140403

Published: 2020

Journal Articles

A New Cellular Immunotherapy for the Treatment of Multiple Myeloma without Development of Graft-Versus-Host Disease

Michael A Firer, PhD, Sofi Yado, BSc, MSc, Luboshits Galia, PhD, Reuven Or, MD

Blood (2018) 132 (Supplement 1): 3339.

https://doi.org/10.1182/blood-2018-99-110292

Published: 2018

Journal Articles

G-CSF Vs Haematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia with ELANE Mutation: Role of G-CSF Dose. a Retrospective Controlled Study on Behalf of Saawp (Severe Aplastic Anemia Working Party) of the EBMT, of the Stem Cell Transplant for Immunodeficiency Group in Europe (SCETIDE), of the Severe Chronic Neutropenia French Registry (SCNFR) and Italian Neutropenia Registry (INR)

Blood (2017) 130 (Supplement 1): 2267.

https://doi.org/10.1182/blood.V130.Suppl_1.2267.2267

Published: 2017

Journal Articles

The CXCR4 Antagonist BL-8040 Induces a Robust Mobilization of CD34+CD38−CD45RA−CD90+ CD49f+ HSCs with Long-Term and Secondary Myeloid and Lymphoid Repopulating Activity

Michal Abraham, PhD, Galia Oberkovitz, PhD, Baruch Bulvik, Klein Shiri, Hanna Wald, Orly Eizenberg, Katia Beider, Arnon Nagler, MD, Abi Vainstein, MD, Eyal Benami, Rotem Golan, Eithan Galun, Yoseph Caraco, Reuven Or, MD, Amnon Peled

Blood (2017) 130 (Supplement 1): 660.

https://doi.org/10.1182/blood.V130.Suppl_1.660.660

Published: 2017

Journal Articles

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Andre Manfred Willasch, MD, Christina Peters, MD, Petr Sedlacek, MD, Jean-Hugues Dalle, MD, Stelios Graphakos, MD, Akif Yesilipek, MD, Jacek Wachowiak, Prof MDPhD, Arjan Lankester, MD PhD, Arcangelo Prete, MD, Amir Ali Hamidieh, MD, Marianne Ifversen, Jochen Büchner, MDPhD, Gergely Krivan, MD, Rose-Marie Hamladji, MD, Cristina Diaz de Heredia, MD, Elena Skorobogatova, MD PhD, Gerard Michel, MD, Franco Locatelli, MD PhD, Alice Bertaina, MD PhD, Paul Veys, MD, Sophie Dupont, MD, Reuven Or, MD, Tayfun Guengoer, Olga Aleinikova, MD PhD, Sabina Sufliarska, MD, Mikael Sundin, MD PhD, Jelena Rascon, MD, Ain Kaare, MD, Damir Nemet, MD PhD, Franca Fagioli, MD, Thomas Klingebiel, MD, Jan Styczynski, PhD, Marc B Bierings, MDPhD, Kalman Nagy, MD, Manuel Abecasis, MD, Boris V Afanasyev, MD PhD Professor, Marc Ansari, MD, Arnaud Dalissier, Myriam Labopin, MD, Eric Beohou, Peter Bader, MD PhD

Blood (2017) 130 (Supplement 1): 911.

https://doi.org/10.1182/blood.V130.Suppl_1.911.911

Published: 2017

Journal Articles

Incidence and Risk Factors For Veno-Occlusive Disease Of The Liver After Allogeneic Stem Cell Transplantation Using a Reduced Intensity Regimen

Panagiotis Tsirigotis, Igor B Resnick, Batia Ronit Avni, M.D., Sigal Grisariu, MD, Polina Stepensky, Reuven Or, MD, Michael Y Shapira, MD

Blood (2013) 122 (21): 4562.

https://doi.org/10.1182/blood.V122.21.4562.4562

Published: 2013

Journal Articles

Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT

Sandra Eder, MD, Myriam Labopin, MD, William Arcese, MD, Reuven Or, MD, Ignazio Majolino, Andrea Bacigalupo, MD, Gennaro de Rosa, Liisa Volin, Dietrich Beelen, MD, Hendrik Veelken, MD PhD, Nicolaas PM Schaap, MD, PhD, Jurgen H Kuball, MD, PhD, Jan Cornelissen, MD, PhD, Arnon Nagler, MD, MSc, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 2123.

https://doi.org/10.1182/blood.V122.21.2123.2123

Published: 2013

Journal Articles

Second Allogeneic Stem Cell Transplantation (AlloSCT) In Patients With Relapsed Lymphoma After First Allosct. A Retrospective Study Of The EBMT Lymphoma Working Party

Kristin Horstmann, Ariane Boumendil, PhD, Herve Finel, Jane F. Apperley, MBChB, FRCP, FRCPath, Fabio Ciceri, MD, Juergen Finke, MD, Achiel Van Hoof, Norbert Ifrah, MD, Slawomira Kyrcz-Krzemien, MD, Gustavo Milone, Ghulam J Mufti, FRCP, FRCPath, Elizabeth Naparstek, MD, Reuven Or, MD, Nigel H Russell, MD, Peter Dreger, MD

Blood (2013) 122 (21): 4632.

https://doi.org/10.1182/blood.V122.21.4632.4632

Published: 2013

Journal Articles

Outcomes Of Allogeneic Cord Blood Transplantation For Leukodystrophies; A Joint Study of Eurocord and “Inborn Errors WP-EBMT”

Blood (2013) 122 (21): 2101.

https://doi.org/10.1182/blood.V122.21.2101.2101

Published: 2013

Journal Articles

Significance of Busulfan Dose Intensity On Outcomes of Hematopoietic Cell Allografting for AML in Second Complete Remission or Beyond: A Report From the EBMT Acute Leukemia Working Party

Ali Bazarbachi, MD, PhD, Myriam Labopin, Mohamed A. Kharfan-Dabaja, MD, Gérard Socié, MD PhD, Nicolaus Kröger, Didier Blaise, MD, Hendrik Veelken, MD PhD, Arancha Bermudez, Reuven Or, MD, Bruno Lioure, MD, Dietrich Beelen, Nathalie Fegueux, MD, Rose-Marie Hamljadi, Arnon Nagler, Mohamad Mohty, MD, PhD

Blood (2012) 120 (21): 1929.

https://doi.org/10.1182/blood.V120.21.1929.1929

Published: 2012

Journal Articles

Comparative Efficacy Analysis of Busulfan Dose Intensity Between Two Reduced Intensity Conditioning Regimens (FB2 vs. FB4) for Allogeneic HCT for AML in First Complete Remission: A Report From the EBMT Acute Leukemia Working Party

Mohamed A Kharfan-Dabaja, MD, Myriam Labopin, Ali Bazarbachi, MD, PhD, Rose-Marie Hamljadi, Didier Blaise, MD, Gérard Socié, MD PhD, Bruno Lioure, MD, Arancha Bermudez, MD, Dolores Caballero, MD, Reuven Or, MD, William Arcese, MD, Nathalie Fegueux, MD, Arnon Nagler, Mohamad Mohty, MD, PhD

Blood (2012) 120 (21): 4153.

https://doi.org/10.1182/blood.V120.21.4153.4153

Published: 2012

Journal Articles

Single-Infusion of Donor Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantati

Dror Mevorach, Inna Reiner, Reuven Or, MD

Blood (2012) 120 (21): 4176.

https://doi.org/10.1182/blood.V120.21.4176.4176

Published: 2012

Journal Articles

Correction of Post-Transplant Hematopoiesis by Novel Use of Mesenchymal-Like Placental Expanded Cells (PLX) Administered Intra-Muscular

Reuven Or, MD, Sigal Grisaro, M.D., Batia Ronit Avni, M.D., Igor Resnick, M.D. PhD, Lilyan Dari, David Shoshani, M.D., Dalia Bracha, RN, MPA, Nurit Beilin, DVM, Limor Lior, MSc, Michael Y. Shapira, MD

Blood (2012) 120 (21): 4133.

https://doi.org/10.1182/blood.V120.21.4133.4133

Published: 2012

Journal Articles

A Multi-Center Prospective Randomized Study Comparing Ibritumomab Tiuxetan (Zevalin) and High-Dose BEAM Chemotherapy (Z-BEAM) Vs. BEAM Alone as the Conditioning Regimen Prior to Autologous Stem-Cell Transplantation In Patients with Aggressive Lymphoma; Possible Advantage for Z-BEAM In Low-Risk Patients

Avichai Shimoni, MD, Irit Avivi, MD, Jacob M. Rowe, Moshe Yeshurun, MD, Itai Levi, MD, Reuven Or, MD, Paulina Patachenko, MD, Abraham Avigdor, MD, Tzila Zwas, MD, Arnon Nagler, M.D.

Blood (2010) 116 (21): 686.

https://doi.org/10.1182/blood.V116.21.686.686

Published: 2010

Journal Articles

Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells.

Igor B Resnick, Jr., MD, PhD, DSci, Polina Stepensky, MD, Michael Y. Shapira, MD, Claudine Barkatz, MSc, Gregory Elkin, PhD, Olga Gurevich, PhD, Avichai Shimoni, MD, Nira Varda-Bloom, PhD, Moshe Yeshurun, MD, Amos Toren, Sr., MD, PhD, Tsila Zukerman, MD, Michael Weintraub, Sr., MD, Arnon Nagler, MD, Reuven Or, MD

Blood (2009) 114 (22): 2249.

https://doi.org/10.1182/blood.V114.22.2249.2249

Published: 2009

Journal Articles

Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD).

Michael Y. Shapira, MD, Allan I. Bloom, MD, Reuven Or, MD, Igor B. Resnick, MD, PhD, DSc, Memet Aker, MD, Shimon Slavin, MD, Anthony Verstandig, MD

Blood (2007) 110 (11): 4960.

https://doi.org/10.1182/blood.V110.11.4960.4960

Published: 2007

Journal Articles

Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-Donors (MDT) in Humans Offers Better Engraftment as Compared to Single Haploidentical Donor.

Michael Y. Shapira, MD, Igor B. Resnick, MD DSc PhD, Benjamin Gesundeheidt, MD PhD, Simcha Samuel, MSc, Liliane Drey, RN, Yuri Verkholevsky, RN BA, Shimon Slavin, MD, Reuven Or, MD

Blood (2007) 110 (11): 4854.

https://doi.org/10.1182/blood.V110.11.4854.4854

Published: 2007

Journal Articles

Thymoglobulin ® Rabbit Anti-Thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and Does Not Suppress Granulocyte Engraftment in a Non-Myeloablative Stem Cell Transplantation Setting.

Michael Y. Shapira, MD, Igor B. Resnick, MD PhD DSc, Benjamin Gesundeheidt, MD PhD, Menachem Bitan, Aliza Ackerstein, MSc, Simcha Samuel, MSc, Liliane Drey, RN BA, Yuri Verkholevsky, RN BA, Shimon Slavin, MD, Reuven Or, MD

Blood (2007) 110 (11): 4942.

https://doi.org/10.1182/blood.V110.11.4942.4942

Published: 2007

Journal Articles

Transplantation from Related and Unrelated Donors in Elderly Patients - Equal Toxicity and Survival.

Michael Y. Shapira, MD, Panagiotis D. Tsirigotis, MD PhD, Reuven Or, MD, Igor B. Resnick, MD PhD, Menachem Bitan, MD, Benjamin Gesundheit, MD PhD, Shimon Slavin

Blood (2006) 108 (11): 5256.

https://doi.org/10.1182/blood.V108.11.5256.5256

Published: 2006

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia.

Michael Y. Shapira, MD, Tsirigotis D. Panagiotis, MD PhD, Reuven Or, MD, Igor B. Resnick, MD PhD, Benjamin Gesundheit, MD, Shimon Slavin, MD

Blood (2006) 108 (11): 3038.

https://doi.org/10.1182/blood.V108.11.3038.3038

Published: 2006

NARROW

Biomarker Analysis in Patients (pts) with Steroid-Refractory Acute Graft-Vs-Host Disease (aGVHD) Treated with Ruxolitinib (RUX) or Best Available Therapy (BAT) in the Randomized, Phase 3 REACH2 Study

A New Cellular Immunotherapy for the Treatment of Multiple Myeloma without Development of Graft-Versus-Host Disease

The CXCR4 Antagonist BL-8040 Induces a Robust Mobilization of CD34+CD38−CD45RA−CD90+ CD49f+ HSCs with Long-Term and Secondary Myeloid and Lymphoid Repopulating Activity

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Incidence and Risk Factors For Veno-Occlusive Disease Of The Liver After Allogeneic Stem Cell Transplantation Using a Reduced Intensity Regimen

Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT

Second Allogeneic Stem Cell Transplantation (AlloSCT) In Patients With Relapsed Lymphoma After First Allosct. A Retrospective Study Of The EBMT Lymphoma Working Party

Outcomes Of Allogeneic Cord Blood Transplantation For Leukodystrophies; A Joint Study of Eurocord and “Inborn Errors WP-EBMT”

Significance of Busulfan Dose Intensity On Outcomes of Hematopoietic Cell Allografting for AML in Second Complete Remission or Beyond: A Report From the EBMT Acute Leukemia Working Party

Comparative Efficacy Analysis of Busulfan Dose Intensity Between Two Reduced Intensity Conditioning Regimens (FB2 vs. FB4) for Allogeneic HCT for AML in First Complete Remission: A Report From the EBMT Acute Leukemia Working Party

Single-Infusion of Donor Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantati

Correction of Post-Transplant Hematopoiesis by Novel Use of Mesenchymal-Like Placental Expanded Cells (PLX) Administered Intra-Muscular

Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells.

Intra-Arterial Catheter Directed Immunosuppressive Therapy for Steroid Resistant or Dependent Graft vs. Host Disease (GVHD).

Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-Donors (MDT) in Humans Offers Better Engraftment as Compared to Single Haploidentical Donor.

Thymoglobulin ® Rabbit Anti-Thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and Does Not Suppress Granulocyte Engraftment in a Non-Myeloablative Stem Cell Transplantation Setting.

Transplantation from Related and Unrelated Donors in Elderly Patients - Equal Toxicity and Survival.

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only